Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.

Source:http://linkedlifedata.com/resource/pubmed/id/15972960

Download in:

View as

General Info

PMID
15972960